Nicholas Michael Mordwinkin - 01 Aug 2022 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role
Chief Business Officer
Signature
/s/ Marc Belsky, Attorney-in-Fact
Issuer symbol
KZR
Transactions as of
01 Aug 2022
Net transactions value
$0
Form type
4
Filing time
02 Aug 2022, 16:47:31 UTC
Previous filing
15 Jul 2022
Next filing
10 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KZR Employee Stock Option (right to buy) Award $0 +200,000 $0.000000 200,000 01 Aug 2022 Common Stock 200,000 $9.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty five percent (25%) of the shares will vest on July 11, 2023, and 1/48th of the total shares will vest each month thereafter, subject to Reporting Person continuing to provide service through such date.